Adam Kroetsch is a Research Director at the Duke-Robert J. Margolis, MD, Center for Health Policy in Washington, DC, where he oversees the Center’s portfolio of research on biomedical innovation and regulatory science, including research on pharmaceutical quality and drug shortages. Before joining the Duke-Margolis Center, Adam worked at the FDA for over a decade. Most recently, Adam served as the deputy director of the FDA Drug Center’s Office of Program and Strategic Analysis, in which he supported the agency’s efforts to address drug shortages through policy analysis, modeling, and analytics.
The publication of the Stigler Center at
The University of Chicago Booth School of Business
ProMarket is dedicated to discussing how competition tends to be subverted by special interests.
The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty.
For more information, please visit ProMarket Policy.